Emerging evidence has indicated that circRNAs are involved in many pathophysiological processes in many human diseases. [4] [5] [6] [7] In the study field of tumorigenesis and progression, recent studies have revealed that certain circRNAs are deregulated in many kinds of human cancers through high-throughput RNA sequencing, such as gastric cancer, breast cancer, basal cell carcinoma, and cutaneous squamous cell carcinoma. [8] [9] [10] [11] Furthermore, several aberrant circRNAs have been identified as oncogenes or tumor suppressors. [12] [13] [14] However, the expression and functions of most deregulated circRNAs remain largely unknown, and the mechanisms are rarely uncovered.
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in men and the second in women worldwide. It is the fourth leading cause of cancer death worldwide. 15, 16 Although the diagnostic methods and treatments have been developed, CRC is still a stable contributor to cancer deaths for lack of sensitive, specific diagnostic biomarkers and effective targets. Therefore, exploring the molecular mechanism underlying CRC carcinogenesis and metastasis may provide novel insight into CRC diagnosis and therapy. As is known, ncRNAs, such as miRNAs, lncRNAs are involved in the development and progression of CRC. 17 However, as a novel identified ncRNAs, the relationship between circRNAs and CRC development is still unknown.
18
Based on the previous studies, 19, 20 which identified the deregulated circRNAs in CRC samples and normal colorectal tissues by high-throughput RNA sequencing, we focused on hsa_ circ_0000567 (http://circbase.org/cgi-bin/simplesearch.cgi) for it is one of the most obviously downregulated circRNAs in CRC tissues.
Hsa_circ_0000567 is located at chr14: 99924616-99932150, and its spliced mature sequence length is 683 nt. Hsa_circ_0000567 is derived from exon 2-6 of SET domain-containing 3 (SETD3). The expression and function of hsa_circ_0000567 in CRC have not yet been known. In this study, we first elucidated hsa_circ_0000567
was downregulated in CRC, and knockdown of hsa_circ_0000567
promoted CRC cells proliferation and migration in vitro. In addition, the diagnostic value of hsa_circ_0000567 was assessed. Our findings indicate that hsa_circ_0000567 may be related to the growth and metastasis of CRC and can serve as a promising diagnostic biomarker for CRC.
| MATERIALS AND METHODS

| Cell culture
Normal human colorectal epithelial cell line (FHC) and 5 CRC cell lines (SW480, RKO, CACO2, SW620, and HCT116) were purchased from the American Type Culture Collection (ATCC, USA). All cell lines were cultured in RPMI-1640 Medium (Gibco, USA) supplemented with 10% fetal bovine serum (Gibco, USA) at 37°C with 5% CO 2 . 
| Tissue samples collection
| RNA extraction and reverse transcription (RT)
Total RNA from tissues or cells was extracted using RNAiso Plus reagent (Takara, Japan) following the manufacturer's instructions.
Then, chloroform was added to separate organic phase from inorganic phase. The isopropanol was used for the precipitation of total RNA. RNA reverse transcription reaction was performed with Reverse Transcription Kit (Takara, Japan).
| Quantitative real-time polymerase chain reaction (qRT-PCR)
qRT-PCR was performed using Sybr Green qPCR master mix (DBI Bioscience, Germany) according to the manufacturer's instructions. The threshold cycle (C t ) value for each sample was obtained through ABI 7500 software v2.0.6, and the ΔC t value was calculated by normalizing to the GAPDH mRNA or 18S rRNA ap-
The relative RNA expression was calculated using the 2 −ΔΔC t method. 21 
| RNase R digestion and Actinomycin
D treatment
RNA samples were degraded using RNase R (2 U/μg RNA, Epicentre
Biotechnologies, USA) for 0, 5, 15, 20 minutes at 37°C and then subjected to qRT-PCR as described above. In addition, SW480 cells were treated with 50 ng/mL Actinomycin D (Amresco, USA) to block new RNA synthesis for 24 hours, and then, total RNA was extracted and qRT-PCR was performed.
| Small interfering RNA (siRNA) and transfection
The siRNA used to inhibit hsa_circ_0000567 expression was purchased from RiboBio (Guangzhou, China), and the sequences are TAAAGTCATCCAGTCAGAA. Cells were transfected with siRNA oligonucleotides using Lipofectamine 3000 (Invitrogen, USA) according to the manufacturer's instructions.
| MTT proliferation assay
About 1 × 10 3 cells suspended in 100 μL culture medium were seeded in 96-well plates, and 50 μL 1× MTT (KeyGen, China) per well was added at 1, 2, 3, 4, 5 days. After incubated at 37°C for a further 4 hours, MTT was removed, and 150 μL DMSO (Sigma, Japan) was added to dissolve the formazan. Absorbance was detected at 570 nm.
F I G U R E 2 Hsa_circ_0000567 was more stable than linear RNA.
(A) qRT-PCR was performed to detect hsa_circ_0000567 and GAPDH mRNA after digested with RNase R (2 U/μg RNA) for the indicated time points. (B) The levels of hsa_circ_0000567 and GAPDH mRNA were measured by qRT-PCR normalizing to 18S rRNA in SW480 cells after treated with Actinomycin D (50 ng/mL) for 24 h. *P < .05, **P < .01, ***P < .001, ****P < .0001 
| Cell migration assay
Transwell chamber (BD Company, USA) was used for migration assay.
About 1 × 10 5 cells suspended in 250 μL serum-free medium were placed in the upper chamber, and 600 μL medium with 20% FBS was added to the lower chamber. After cultured for 36 hours, the nonmigrated cells were erased, and the migrated cells were stained using Giemsa (KeyGen, China). The cells were captured in 5 fields (× 200) under a microscope and counted.
| Statistical analysis
Statistical analyses were performed using SPSS 20.0 software (IBM, USA) and GraphPad Prism version 6.0. Data were presented as mean ± standard deviation (SD). The differences between groups were tested using a two-tailed Student's t test. The relationships between hsa_circ_0000567 expression levels and clinicopathological factors of patients with CRC were analyzed by a two-tailed Student's t test or one-way analysis of variance (ANOVA). The receiver operating characteristic (ROC) curve was built using GraphPad Prism.
Differences were considered significant if P < .05. *P < .05, **P < .01, ***P < .001, ****P < .0001.
| RESULTS
| Validation of hsa_circ_0000567 in CRC tissues and CRC cell lines
Hsa_circ_0000567 is derived from exon 2-6 of SETD3 gene locus by back-splicing. We designed the divergent primers crossing the back-splice junction for detecting hsa_circ_0000567 expression ( Figure 1A ). The melt curve analysis of qRT-PCR yielded only a single peak, demonstrating the amplified product was specific without nonspecific amplification or primer dimmers ( Figure 1B) . Subsequently, the Sanger sequencing of the amplified product confirmed the existence of back-splice junction ( Figure 1C ). These results demonstrate that hsa_circ_0000567 exists in CRC and can be detected specifically by qRT-PCR.
| Hsa_circ_0000567 was more stable than linear RNA
As circRNAs can resist the digestion of RNase R for lack of free 5′-and 3′-ends, we used RNase R to test the stability of hsa_circ_0000567.
Results indicated hsa_circ_0000567 was more stable than the endogenous linear GAPDH mRNA (Figure 2A ). Additionally, SW480 cells were treated with Actinomycin D to block new RNA synthesis for 24 hours. As a result, hsa_circ_0000567 levels were not obviously changed, while GAPDH mRNAs were significantly decreased (P < .05) ( Figure 2B ).
| Hsa_circ_0000567 was downregulated in CRC and associated with tumor growth and metastasis of patients with CRC
We detected the expression of hsa_circ_0000567 in 102 pairs of CRC tissues and adjacent noncancerous tissues using qRT-PCR. The results showed that hsa_circ_0000567 was lower in 96 of 102 cases of CRC samples compared with those of the counterparts (P < .0001) ( Figure 3A ,B).
To further investigate the clinical significance of hsa_circ_0000567
in CRC, we analyzed the relationship between the expression of hsa_circ_0000567 and the clinicopathological features of patients with CRC. As shown in Table 1 , hsa_circ_0000567 expression was negatively correlated with tumor size (P = .011), lymph metastasis (P = .003), distal metastasis (P < .0001), and tumor-node-metastasis (TNM) stage (P = .003) in CRC. The bold values denote the differences between groups are significant.
We also examined hsa_circ_0000567 expression levels in CRC cell expression was significantly lower in highly metastatic CRC cell line SW620 compared with the low metastasis cell line SW480 (P < .0001, Figure 3C ). These results demonstrate hsa_circ_0000567 may play a suppressor role in CRC growth and metastasis.
| Knockdown of hsa_circ_0000567 promoted CRC cells proliferation and migration in vitro
To further verify the inhibitory role of hsa_circ_0000567 in CRC,
we performed the loss-of-function assay in vitro. We chose SW480
and CACO2 cells because hsa_circ_0000567 expression could be knocked down more efficiently in them than in the other cell lines using siRNA. qRT-PCR revealed hsa_circ_0000567 expression was significantly reduced in SW480 and CACO2 cells after transfection with hsa_circ_0000567 siRNA ( Figure 4A ). MTT assay showed that cell proliferation ability was enhanced after knockdown of hsa_ circ_0000567 expression ( Figure 4B ). Furthermore, repression of hsa_circ_0000567 expression promoted the migration of CRC cells ( Figure 4C ).
| Potential diagnostic value of hsa_circ_0000567 in CRC
We have verified hsa_circ_0000567 was deregulated in CRC and more stable than linear RNA, which suggests hsa_circ_0000567 may serve as a promising biomarker. To evaluate the diagnostic value of hsa_circ_0000567 in CRC, we built a ROC curve using the expression of hsa_circ_0000567 in CRC tissues and adjacent noncancerous tissues.
The calculated area under the ROC curve (AUC) was 0.8653, which means the higher diagnostic value of hsa_circ_0000567 in CRC. The sensitivity, specificity, Youden's index, and cut-off value were 0.8333, 0.7647, 0.598, and 0.4714, respectively ( Figure 5 ). In addition, we found that hsa_circ_0000567 in human blood exosome from the patients with CRC was also lower than that from the normal individuals in exoRBase ( Figure S1 ), which suggests the circulating hsa_circ_0000567 may also be used as a diagnostic biomarker. However, future work is needed to validate the diagnostic value of hsa_circ_0000567 in blood exosome. 
26,27
To our best knowledge, this is the first study to elucidate the expression, function, and diagnostic value of hsa_circ_0000567 in CRC. We validated the existent of hsa_circ_0000567 in CRC tissues was identified as a prognostic biomarker in colorectal cancer. [28] [29] [30] In this study, we investigated that hsa_circ_0000567 was downregulated in CRC tissues and CRC cell lines (Figure 3) . Furthermore, we confirmed that hsa_circ_0000567 expression in CRC tissues can be used to diagnose CRC by building a ROC curve ( Figure 5 ). In addition, body fluids are convenient in the diagnosis of human diseases, and certain circRNAs were abundant and stable in plasma or exosomes. 31, 32 We found that hsa_circ_0000567 in blood exosomes from patients with CRC was also decreased compared with that from normal persons in exoRBase, indicating the circulating hsa_circ_0000567 may be used as a biomarker for CRC screening ( Figure S1 ). However, future work still needs to be done to examine hsa_circ_0000567 level in exosomes from clinical samples.
Previous studies have reported that circRNAs play a crucial role in cancer biological processes, such as proliferation, migration, and metastasis. [33] [34] [35] [36] Our study revealed that the decreased hsa_circ_0000567 was negatively correlated with tumor size, lymph metastasis, distal metastasis, and TNM stage in patients with CRC (Table 1) . Consistent with the findings in CRC tissue samples, hsa_circ_0000567 expression in CRC cell lines was also associated with the metastasis ability of cells ( Figure 3C ). These results suggest hsa_circ_0000567 may be involved in the growth and metastasis of cells. Subsequently, the hypothesis was verified by the loss-of-function assay in vitro ( Figure 4 ).
As hsa_circ_0000567 is generated from exons of SETD3 gene, as an ecircRNAs, it is possibly located in the cytoplasm and may function as miRNA sponges or bind to proteins to regulate gene expression at the post-transcriptional level according to previous studies. 24, 25 Future work is needed to uncover the mechanisms of hsa_circ_0000567 in CRC progression.
In summary, our data identified hsa_circ_0000567 plays a suppressor role in CRC proliferation and metastasis. More importantly, hsa_circ_0000567 may serve as a potential novel biomarker for the diagnosis of CRC. 
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